INSP — Inspire Medical Systems Share Price
0.000.00%
Last trade - 00:00- $4.73bn
- $4.29bn
- $802.80m
- 89
- 13
- 84
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 63.81 | ||
| PEG Ratio (f) | 2.61 | ||
| EPS Growth (f) | 32.32% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.86 | ||
| Price to Tang. Book | 6.86 | ||
| Price to Free Cashflow | 51.95 | ||
| Price to Sales | 5.9 | ||
| EV to EBITDA | 100.46 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.01% | ||
| Return on Equity | 8.48% | ||
| Operating Margin | 4.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 115.38 | 233.39 | 407.86 | 624.8 | 802.8 | 949.65 | 1,115.58 | 57.8% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +23.69 | +47.3 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Directors
- Marilyn Nelson CHM (81)
- Timothy Herbert PRE (58)
- Richard Buchholz CFO (53)
- Philip Ebeling COO (50)
- Bryan Phillips SVP (49)
- Steven Jandrich VPR (54)
- Randall Ban OTH (56)
- Shelley Broader IND (56)
- Gary Ellis IND (64)
- Georgia Garinois- Melenikiotou IND (61)
- Jerry Griffin IND (76)
- Shawn McCormick IND (56)
- Dana Mead IND (62)
- Casey Tansey IND (63)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 13th, 2007
- Public Since
- May 3rd, 2018
- No. of Shareholders
- 12
- No. of Employees
- 1,246
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 29,759,651
- Address
- 5500 Wayzata Blvd Ste 1600, GOLDEN VALLEY, 55416-1237
- Web
- https://www.inspiresleep.com/
- Phone
- +1 7639575037
- Contact
- Ezgi Yagci
- Auditors
- Ernst & Young LLP
Upcoming Events for INSP
Q1 2025 Inspire Medical Systems Inc Earnings Release
Q1 2025 Inspire Medical Systems Inc Earnings Call
Inspire Medical Systems Inc Annual Shareholders Meeting
Q2 2025 Inspire Medical Systems Inc Earnings Release
Similar to INSP
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
What is the Inspire Medical Systems share price?
As of Today at 21:20 UTC, shares in Inspire Medical Systems are trading at $159.06. This share price information is delayed by 15 minutes.
How has the Inspire Medical Systems share price performed this year?
Shares in Inspire Medical Systems last closed at $159.06 and the price had moved by -31.15% over the past 365 days. In terms of relative price strength the Inspire Medical Systems share price has underperformed the S&P500 Index by -36.45% over the past year.
What are the analyst and broker recommendations for Inspire Medical Systems?
The overall consensus recommendation for Inspire Medical Systems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Inspire Medical Systems dividend yield?
Inspire Medical Systems does not currently pay a dividend.
Does Inspire Medical Systems pay a dividend?
Inspire Medical Systems does not currently pay a dividend.
When does Inspire Medical Systems next pay dividends?
Inspire Medical Systems does not currently pay a dividend.
How do I buy Inspire Medical Systems shares?
To buy shares in Inspire Medical Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Inspire Medical Systems?
As of the previous close price of $159.06, shares in Inspire Medical Systems had a market capitalisation of $4.73bn.
Where are Inspire Medical Systems shares listed?
Here are the trading details for Inspire Medical Systems:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: INSP
What kind of share is Inspire Medical Systems?
Based on an overall assessment of its quality, value and momentum Inspire Medical Systems is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Inspire Medical Systems share price forecast for 2025?
The analyst consensus target price for shares in Inspire Medical Systems is $223.45. That is 40.48% above the last closing price of $159.06.
Analysts covering Inspire Medical Systems currently have a consensus Earnings Per Share (EPS) forecast of $2.17 for the next financial year.
Find out moreWhat is the trend in the Inspire Medical Systems share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Inspire Medical Systems. Over the past six months, its share price has underperformed the S&P500 Index by -14.11%.
As of the last closing price of $159.06, shares in Inspire Medical Systems were trading -12.31% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Inspire Medical Systems PE Ratio?
The Inspire Medical Systems PE ratio based on its reported earnings over the past 12 months is 63.81. The shares last closed at $159.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Inspire Medical Systems?
Inspire Medical Systems' management team is headed by:
- Marilyn Nelson - CHM
- Timothy Herbert - PRE
- Richard Buchholz - CFO
- Philip Ebeling - COO
- Bryan Phillips - SVP
- Steven Jandrich - VPR
- Randall Ban - OTH
- Shelley Broader - IND
- Gary Ellis - IND
- Georgia Garinois- Melenikiotou - IND
- Jerry Griffin - IND
- Shawn McCormick - IND
- Dana Mead - IND
- Casey Tansey - IND